BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46. [PMID: 8508710 DOI: 10.1007/BF01295733] [Cited by in Crossref: 266] [Cited by in F6Publishing: 234] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Kwon Y, Kim ES, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World J Gastroenterol 2022; 28(28): 3666-3681 [DOI: 10.3748/wjg.v28.i28.3666] [Reference Citation Analysis]
2 Gaweł K, Dąbkowski K, Zawada I, Starzyńska T. Progression risk factors of ulcerative proctitis. Scand J Gastroenterol 2022;:1-6. [PMID: 35793351 DOI: 10.1080/00365521.2022.2094726] [Reference Citation Analysis]
3 Chiarello MM, Pepe G, Fico V, Bianchi V, Tropeano G, Altieri G, Brisinda G. Therapeutic strategies in Crohn’s disease in an emergency surgical setting. World J Gastroenterol 2022; 28(18): 1902-1921 [DOI: 10.3748/wjg.v28.i18.1902] [Reference Citation Analysis]
4 Albayrak NE, Polydorides AD. Characteristics and Outcomes of Left-sided Ulcerative Colitis With a Cecal/Periappendiceal Patch of Inflammation. Am J Surg Pathol 2022. [PMID: 35354161 DOI: 10.1097/PAS.0000000000001883] [Reference Citation Analysis]
5 Cleveland NK, Torres J, Rubin DT. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology 2022:S0016-5085(22)00077-4. [PMID: 35101421 DOI: 10.1053/j.gastro.2022.01.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
6 Lamb CA, Saifuddin A, Powell N, Rieder F. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 2022;162:1525-42. [PMID: 34995532 DOI: 10.1053/j.gastro.2021.09.077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Carvello M, Watfah J, Spinelli A. The Management of the Hospitalized Ulcerative Colitis Patient, the Medical-Surgical Conundrum. Curr Gastroenterol Rep 2021;23:25. [PMID: 34716521 DOI: 10.1007/s11894-021-00820-7] [Reference Citation Analysis]
8 Christensen B, Hanauer SB, Gibson PR, Turner JR, Hart J, Rubin DT. Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. J Crohns Colitis 2020;14:1345-53. [PMID: 32267926 DOI: 10.1093/ecco-jcc/jjaa068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Belvedere A, Scoglio R, Viola A, Costantino G, Sitibondo A, Muscianisi M, Inferrera S, Alibrandi A, Fries W. A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy. Acta Biomed 2021;92:e2021161. [PMID: 33988169 DOI: 10.23750/abm.v92i2.9593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Iizuka M, Etou T, Shimodaira Y, Hatakeyama T, Sagara S. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis. World J Gastroenterol 2021; 27(12): 1194-1212 [PMID: 33828394 DOI: 10.3748/wjg.v27.i12.1194] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Niriella MA, Liyanage IK, Kodisinghe SK, De Silva AP, Jayatissa AVGAM, Navarathne NMM, Peiris RK, Kalubovila UP, Kumarasena SR, Jayasekara RW, de Silva HJ. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterol 2021;21:71. [PMID: 33593289 DOI: 10.1186/s12876-021-01644-5] [Reference Citation Analysis]
12 Pabla BS, Schwartz DA. Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:671-88. [PMID: 33121688 DOI: 10.1016/j.gtc.2020.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
13 Pellino G, Keller DS, Sampietro GM, Carvello M, Celentano V, Coco C, Colombo F, Geccherle A, Luglio G, Rottoli M, Scarpa M, Sciaudone G, Sica G, Sofo L, Zinicola R, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F; Italian Society of Colorectal Surgery SICCR. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. Tech Coloproctol 2020;24:397-419. [PMID: 32124113 DOI: 10.1007/s10151-020-02175-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
14 Carvello M, Watfah J, Włodarczyk M, Spinelli A. The Management of the Hospitalized Ulcerative Colitis Patient: the Medical-Surgical Conundrum. Curr Gastroenterol Rep 2020;22:11. [PMID: 32040642 DOI: 10.1007/s11894-020-0750-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ghoz H, Kesler A, Hoogenboom SA, Gavi F, Brahmbhatt B, Cangemi J, Kröner PT. Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control? J Gastrointest Surg 2020;24:270-7. [PMID: 31797257 DOI: 10.1007/s11605-019-04474-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Burisch J, Ungaro R, Vind I, Prosberg MV, Bendtsen F, Colombel JF, Vester-Andersen MK. Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. J Crohns Colitis 2017;11:1200-4. [PMID: 28486626 DOI: 10.1093/ecco-jcc/jjx066] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
17 Massinha P, Portela F, Campos S, Duque G, Ferreira M, Mendes S, Ferreira AM, Sofia C, Tomé L. Ulcerative Colitis: Are We Neglecting Its Progressive Character. GE Port J Gastroenterol 2018;25:74-9. [PMID: 29662931 DOI: 10.1159/000481263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Akpinar MY, Ozin YO, Kaplan M, Ates I, Kalkan IH, Kilic ZMY, Yuksel M, Kayacetin E. Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis. J Med Biochem. 2018;37:155-162. [PMID: 30581352 DOI: 10.1515/jomb-2017-0050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
19 Lian L, Obusez E, Remer EM, Monga M, Shen B. Clinical Implication of Enlarged Prostate in Patients with the Ileal Pouch-anal Anastomosis for Inflammatory Bowel Disease. Gastroenterology Res 2018;11:5-10. [PMID: 29511399 DOI: 10.14740/gr975e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Bosworth BP, Sandborn WJ, Rubin DT, Harper JR. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Inflamm Bowel Dis 2016;22:1881-6. [PMID: 27416045 DOI: 10.1097/MIB.0000000000000860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study. Gut 2017;66:1912-7. [PMID: 27489240 DOI: 10.1136/gutjnl-2016-311970] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
22 Jajam M, Bozzolo P, Niklander S. Oral manifestations of gastrointestinal disorders. J Clin Exp Dent 2017;9:e1242-8. [PMID: 29167716 DOI: 10.4317/jced.54008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
23 Lee DW, Koo JS, Choe JW, Suh SJ, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ, Lee SW. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol 2017; 23(35): 6474-6481 [PMID: 29085197 DOI: 10.3748/wjg.v23.i35.6474] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 32] [Article Influence: 8.4] [Reference Citation Analysis]
24 Iizuka M, Etou T, Kumagai M, Matsuoka A, Numata Y, Sagara S. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. Intern Med. 2017;56:2705-2710. [PMID: 28924114 DOI: 10.2169/internalmedicine.8428-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
25 Parian A, Limketkai B, Koh J, Brant SR, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro MD, Rioux JD, Schumm P, Taylor KD, Silverberg MS, Steinhart AH, Hernaez R, Lazarev M. Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis. Gut 2017;66:1390-7. [PMID: 27196594 DOI: 10.1136/gutjnl-2016-311550] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
26 Myrelid P, Landerholm K, Nordenvall C, Pinkney TD, Andersson RE. Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study. Am J Gastroenterol. 2017;112:1311-1319. [PMID: 28653667 DOI: 10.1038/ajg.2017.183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
27 Roda G, Narula N, Pinotti R, Skamnelos A, Katsanos KH, Ungaro R, Burisch J, Torres J, Colombel JF. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther 2017;45:1481-92. [PMID: 28449361 DOI: 10.1111/apt.14063] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
28 Sobrado CW, Sobrado LF. MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE. Arq Bras Cir Dig 2016;29:201-5. [PMID: 27759787 DOI: 10.1590/0102-6720201600030017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
29 Sahami S, Konté K, Buskens CJ, Tanis PJ, Löwenberg M, Ponsioen CJ, van den Brink GR, Bemelman WA, D'Haens GR. Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis. United European Gastroenterol J 2017;5:554-62. [PMID: 28588887 DOI: 10.1177/2050640616679552] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
30 Ghanadi K, Valizadeh J, Hasanvand A. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study. Springerplus 2016;5:1588. [PMID: 27652161 DOI: 10.1186/s40064-016-3248-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Permpoon V, Pongpirul K, Anuras S. Ethnic variations in ulcerative colitis: Experience of an international hospital in Thailand. World J Gastrointest Pharmacol Ther 2016; 7(3): 428-433 [PMID: 27602244 DOI: 10.4292/wjgpt.v7.i3.428] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fatemi A, Jazi HH, Emami MH, Kazemizadeh A, Tavakkoli H, Smiley A. Relationship between articular and nonarticular manifestations in inflammatory bowel diseases. J Res Med Sci 2016;21:48. [PMID: 27904594 DOI: 10.4103/1735-1995.183989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Shimoda M, Horiuchi K, Sasaki A, Tsukamoto T, Okabayashi K, Hasegawa H, Kitagawa Y, Okada Y. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation. EBioMedicine 2016;5:114-24. [PMID: 27077118 DOI: 10.1016/j.ebiom.2016.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
34 da Silva BC, Lyra AC, Mendes CM, Ribeiro CP, Lisboa SR, de Souza MT, Portela RC, Santana GO. The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population. Biomed Res Int. 2015;2015:359130. [PMID: 26509150 DOI: 10.1155/2015/359130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
35 Rubin DT, Sandborn WJ, Bosworth B, Zakko S, Gordon GL, Sale ME, Rolleri RL, Golden PL, Barrett AC, Bortey E, Forbes WP. Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. Dig Dis Sci 2015;60:3408-17. [PMID: 26386854 DOI: 10.1007/s10620-015-3868-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
36 Stallmach A, Nickel L, Lehmann T, Bokemeyer B, Bürger M, Hüppe D, Kruis W, Nikolaus S, Preiss JC, Sturm A, Teich N, Schmidt C. Parameters of a severe disease course in ulcerative colitis. World J Gastroenterol 2014; 20(35): 12574-12580 [PMID: 25253960 DOI: 10.3748/wjg.v20.i35.12574] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
37 da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol 2014;20:9458-67. [PMID: 25071340 DOI: 10.3748/wjg.v20.i28.9458] [Cited by in CrossRef: 148] [Cited by in F6Publishing: 120] [Article Influence: 18.5] [Reference Citation Analysis]
38 Kim DH, Park SJ, Park JJ, Yun YH, Hong SP, Kim TI, Kim WH, Cheon JH. Effect of follow-up endoscopy on the outcomes of patients with inflammatory bowel disease. Dig Dis Sci. 2014;59:2514-2522. [PMID: 24838498 DOI: 10.1007/s10620-014-3197-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
39 Pagnini C, Menasci F, Festa S, Rizzatti G, Fave GD. “Mucosal healing” in ulcerative colitis: Between clinical evidence and market suggestion. World J Gastrointest Pathophysiol 2014; 5(2): 54-62 [PMID: 24891976 DOI: 10.4291/wjgp.v5.i2.54] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
40 Marchioni Beery R, Kane S. Current approaches to the management of new-onset ulcerative colitis. Clin Exp Gastroenterol. 2014;7:111-132. [PMID: 24872716 DOI: 10.2147/ceg.s35942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
41 Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20(3): 814-821 [PMID: 24574754 DOI: 10.3748/wjg.v20.i3.814] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
42 Xavier JCC Júnior, Coelho KIR, Sassaki LY, Yamashiro FDS, Oliveira KCL, Rodrigues MAM. Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man. Autops Case Rep 2013;3:37-41. [PMID: 28584805 DOI: 10.4322/acr.2013.037] [Reference Citation Analysis]
43 Chhaya V, Pollok R. The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? F1000Prime Rep 2013;5:50. [PMID: 24273651 DOI: 10.12703/P5-50] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Liasis L, Papaconstantinou HT, Tierris I, Clark CC. Ulcerative colitis in patient with sickle cell disease: A conspiracy of nature that turns surgeon’s decision into a challenge. Hellenic J Surg 2013;85:55-7. [DOI: 10.1007/s13126-013-0008-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
45 Tyler AD, Milgrom R, Stempak JM, Xu W, Brumell JH, Muise AM, Sehgal R, Cohen Z, Koltun W, Shen B, Silverberg MS. The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut 2013;62:1433-9. [PMID: 22879519 DOI: 10.1136/gutjnl-2011-301957] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
46 Tyler AD, Knox N, Kabakchiev B, Milgrom R, Kirsch R, Cohen Z, McLeod RS, Guttman DS, Krause DO, Silverberg MS. Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One. 2013;8:e66934. [PMID: 24086242 DOI: 10.1371/journal.pone.0066934] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
47 Senanayake SM, Fernandopulle AN, Niriella MA, Wijesinghe NT, Ranaweera A, Mufeena MN, Pathmeswaran A, Nawarathne NM, de Silva AP, de Silva HJ. The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clin Exp Gastroenterol. 2013;6:195-200. [PMID: 24068873 DOI: 10.2147/ceg.s49202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
48 Park SH, Yang SK, Hong SM, Park SK, Kim JW, Lee HJ, Yang DH, Jung KW, Kim KJ, Ye BD. Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci. 2013;58:3592-3599. [PMID: 23979435 DOI: 10.1007/s10620-013-2828-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
49 Ward ST, Li KK, Trivedi PJ, Hejmadi RK, Suggett N, Iqbal T, Ismail T. Patients newly diagnosed with ulcerative colitis receive earlier treatment in surgical clinics. Colorectal Dis 2013;15:836-41. [PMID: 23691950 DOI: 10.1111/codi.12142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Bermejo F, Gisbert JP. Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies. Ther Adv Chronic Dis 2010;1:107-14. [PMID: 23251733 DOI: 10.1177/2040622310374897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
51 Moore SE, Raval MJ, Phang TP, Bressler B, Brown CJ; Cochrane Colorectal Cancer Group. Surgery for ulcerative colitis: Outcomes in low volume hospitals versus high volume hospitals. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010175] [Reference Citation Analysis]
52 Turcotte JF, Wong K, Mah SJ, Dieleman LA, Kao D, Kroeker K, Claggett B, Saltzman JR, Wine E, Fedorak RN, Liu JJ. Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel disease. Clin Transl Gastroenterol. 2012;3:e19. [PMID: 23238291 DOI: 10.1038/ctg.2012.13] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
53 Rostholder E, Ahmed A, Cheifetz AS, Moss AC. Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. Aliment Pharmacol Ther. 2012;35:562-567. [PMID: 22239070 DOI: 10.1111/j.1365-2036.2011.04986.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
54 Jones J, Panaccione R, Russell ML, Hilsden R. Medical management of inflammatory bowel disease among Canadian gastroenterologists. Can J Gastroenterol 2011;25:565-9. [PMID: 22059162 DOI: 10.1155/2011/837847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol. 2011;7:29-36. [PMID: 21162647 DOI: 10.1586/eci.10.83] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 6.1] [Reference Citation Analysis]
56 Haritunians T, Taylor KD, Targan SR, Dubinsky M, Ippoliti A, Kwon S, Guo X, Melmed GY, Berel D, Mengesha E, Psaty BM, Glazer NL, Vasiliauskas EA, Rotter JI, Fleshner PR, McGovern DP. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis 2010;16:1830-40. [PMID: 20848476 DOI: 10.1002/ibd.21293] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 10.6] [Reference Citation Analysis]
57 Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One. 2010;5. [PMID: 20957151 DOI: 10.1371/journal.pone.0013160] [Cited by in Crossref: 167] [Cited by in F6Publishing: 188] [Article Influence: 13.9] [Reference Citation Analysis]
58 Slattery E, Keegan D, Hyland J, Mulcahy H, O'Donoghue D. Surgical rates in ulcerative colitis: have we made a difference? Scand J Gastroenterol 2011;46:122-3. [PMID: 20809770 DOI: 10.3109/00365521.2010.516451] [Reference Citation Analysis]
59 Arnell TD. Surgical management of acute colitis and toxic megacolon. Clin Colon Rectal Surg. 2004;17:71-74. [PMID: 20011287 DOI: 10.1055/s-2004-823073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
60 Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010;4:1-14. [PMID: 20479907 DOI: 10.5009/gnl.2010.4.1.1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
61 Roth LS, Chande N, Ponich T, Roth ML, Gregor J. Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario. World J Gastroenterol 2010; 16(2): 232-236 [PMID: 20066743 DOI: 10.3748/wjg.v16.i2.232] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
62 Prantera C, Rizzi M. 5-ASA in ulcerative colitis: Improving treatment compliance. World J Gastroenterol 2009; 15(35): 4353-4355 [PMID: 19764084 DOI: 10.3748/wjg.15.4353] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
63 Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, Park SJ, Yoon CH. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci. 2010;55:1989-1995. [PMID: 19763825 DOI: 10.1007/s10620-009-0963-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
64 Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas JL, Savoye G, Baldé M, Marti R, Lerebours E, Cortot A, Salomez JL, Turck D, Colombel JF. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 2009;104:2080-8. [PMID: 19436273 DOI: 10.1038/ajg.2009.177] [Cited by in Crossref: 209] [Cited by in F6Publishing: 187] [Article Influence: 16.1] [Reference Citation Analysis]
65 Hefti MM, Chessin DB, Harpaz NH, Steinhagen RM, Ullman TA. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum. 2009;52:193-197. [PMID: 19279411 DOI: 10.1007/dcr.0b013e31819ad456] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
66 Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrügger RW. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009;104:371-83. [PMID: 19174787 DOI: 10.1038/ajg.2008.38] [Cited by in Crossref: 202] [Cited by in F6Publishing: 188] [Article Influence: 15.5] [Reference Citation Analysis]
67 Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008;103:3082-93. [PMID: 19086959 DOI: 10.1111/j.1572-0241.2008.02212.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 151] [Article Influence: 11.7] [Reference Citation Analysis]
68 Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-82. [PMID: 19086963 DOI: 10.1111/j.1572-0241.2008.02158.x] [Cited by in Crossref: 361] [Cited by in F6Publishing: 371] [Article Influence: 25.8] [Reference Citation Analysis]
69 Moss AC, Peppercorn MA. Steroid-refractory severe ulcerative colitis: what are the available treatment options? Drugs. 2008;68:1157-1167. [PMID: 18547130 DOI: 10.2165/00003495-200868090-00001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
70 Rioux K. What is the prognosis of ulcerative colitis?: . Inflammatory Bowel Diseases 2008;14:S52-3. [DOI: 10.1097/00054725-200810001-00027] [Reference Citation Analysis]
71 Farmer RG. Inflammatory bowel disease: Does disease location at presentation predict disease course? Inflammatory Bowel Diseases 2008;14:S57-8. [DOI: 10.1097/00054725-200810001-00030] [Reference Citation Analysis]
72 Huguet Malavés JM, Ruiz Sánchez L, Durá Ayet AB, Rodríguez García I, Latorre Sánchez M, Ferrer Arranz L, Tuset Ruiz JA, Tomé Toyosato A, Medina Chuliá E. [Effectiveness of maintenance azathioprine therapy without oral cyclosporine after severe attacks of ulcerative colitis refractory to endovenous steroids]. Gastroenterol Hepatol 2008;31:280-4. [PMID: 18448056 DOI: 10.1157/13119879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Hori K, Ikeuchi H, Nakano H, Uchino M, Tomita T, Ohda Y, Hida N, Matsumoto T, Fukuda Y, Miwa H. Gastroduodenitis associated with ulcerative colitis. J Gastroenterol. 2008;43:193-201. [PMID: 18373161 DOI: 10.1007/s00535-007-2143-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
74 Zamirian M, Aslani A. Response to Dr. Ze-Zhou Song. Am J Gastroenterol 2008;103:241-241. [DOI: 10.1111/j.1572-0241.2007.01562_2.x] [Reference Citation Analysis]
75 Henriksen M, Jahnsen J, Lygren I, Vatn MH, Moum B; IBSEN Study Group. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol 2007;102:1955-63. [PMID: 17573793 DOI: 10.1111/j.1572-0241.2007.01368.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
76 Ando T, Takahashi H, Watanabe O, Maeda O, Ishiguro K, Ishikawa D, Hasegawa M, Ohmiya N, Niwa Y, Goto H. Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol 2007; 13(18): 2523-2528 [PMID: 17551998 DOI: 10.3748/wjg.v13.i18.2523] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
77 Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population. Eur J Gastroenterol Hepatol. 2007;19:217-223. [PMID: 17301648 DOI: 10.1097/01.meg.0000250590.84102.12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
78 Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, Satsangi J. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007;102:589-97. [PMID: 17338737 DOI: 10.1111/j.1572-0241.2007.01065.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
79 Chatzicostas C, Roussomoustakaki M, Potamianos S, Paspatis G, Mouzas I, Romanos J, Mavrogeni H, Kouroumalis E. Factors associated with disease evolution in Greek patients with inflammatory bowel disease. BMC Gastroenterol 2006;6:21. [PMID: 16869971 DOI: 10.1186/1471-230X-6-21] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
80 Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, Satir AA. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol 2006;59:1066-72. [PMID: 16565224 DOI: 10.1136/jcp.2005.034983] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
81 Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, Nicolae DL. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol 2006;101:572-80. [PMID: 16542294 DOI: 10.1111/j.1572-0241.2006.00451.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
82 Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53. [PMID: 15972298 DOI: 10.1136/gut.2005.068809] [Cited by in Crossref: 365] [Cited by in F6Publishing: 338] [Article Influence: 22.8] [Reference Citation Analysis]
83 Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, Matsuda K, Muto T, Nagawa H. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: Results of a 23-year surveillance programme in the Japanese population. Br J Cancer. 2003;89:1232-1236. [PMID: 14520452 DOI: 10.1038/sj.bjc.6601247] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 4.7] [Reference Citation Analysis]
84 Giallourakis C, Stoll M, Miller K, Hampe J, Lander ES, Daly MJ, Schreiber S, Rioux JD. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003;73:205-11. [PMID: 12776251 DOI: 10.1086/376417] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 6.1] [Reference Citation Analysis]
85 Rhodes JM. Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive. Gut 2001;49:322-3. [PMID: 11511550 DOI: 10.1136/gut.49.3.322] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 2001;48:461-7. [PMID: 11247888 DOI: 10.1136/gut.48.4.461] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
87 D'Arienzo A, Scaglione G, Vicinanza G, Manguso F, Bennato R, Belfiore G, Imbriaco M, Mazzacca G. Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis. Am J Gastroenterol 2000;95:720-4. [PMID: 10710064 DOI: 10.1111/j.1572-0241.2000.01841.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
88 Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997;40:328-32. [PMID: 9135520 DOI: 10.1136/gut.40.3.328] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 4.0] [Reference Citation Analysis]
89 Farmer RG. The Doctor?Patient Relationship: Quantification of the Interaction. Ann NY Acad Sci 1994;729:27-35. [DOI: 10.1111/j.1749-6632.1994.tb12207.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]